EPCAM and breast carcinoma: In contrast to the data shown here, the paper by Kruijff et al, describing AR expression in CTCs of metastatic breast cancer patients using the CellSearch system, thus, selecting EpCAM‐positive CTCs for further AR mRNA expression analysis, detected AR + CTCs in only 13% of TNBC cases.